This inventor holds 1 USPTO granted patent. Top assignee: Primoris Therapeutics Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yea-In Lee and Cord Blood Stem Cell Research.
Introduction
Yea-In Lee is an inventor based in Gwangmyeong-si, Gyeonggi-do, South Korea. His patent work concerns the isolation and cultivation of cord blood stem cells expressing GDF-3 at high levels.
Latest Patents
Lee is associated with 1 patent: “Method for Isolating and Culturing Cord Blood Stem Cells Expressing GDF-3 at High Level, and Use of GDF-3.” The invention focuses on methods for isolating and cultivating these cells and their potential use.
Career Highlights
Lee is associated with Primoris Therapeutics Co., Ltd. His listed patent reflects work in stem cell research and biotechnology.
Collaborations
Lee’s listed coworkers include Jae-yong Lee and Hee-Jin Ahn. The available information identifies them as coworkers but does not specify their roles in the patent.
Conclusion
Yea-In Lee’s patent activity centers on cord blood stem cells expressing GDF-3, connecting his work with biotechnology research at Primoris Therapeutics Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile